EndoGastric Solutions Announces Data Presented at ACG 2018 Provide Additional Validation of the Safety and Clinical Efficacy of TIF 2.0 Procedure for the Treatment of GERD »
October 29, 2018
Amit Sohagia, MD received ACG’s Outstanding Poster Presenter Award for TIF 2.0 procedure poster REDMOND, Wash. – EndoGastric®Solutions today announced the presentation of three posters at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting and Postgraduate Course, highlighting the safety and efficacy of Transoral Incisionless Fundoplication (TIF) 2.0 procedure in the treatment of gastroesophageal […] More »
A Novel Laparoendoscopic Approach Delivers Long-Term GERD Relief »
October 26, 2018
Doctor’s Voice Medhat Fanous, MD, General Surgeon, Aspirus Iron River Hospital Gastroesophageal reflux disease (GERD) is a common gastrointestinal disease that affects nearly 20 percent of the U.S. population. Risk factors for developing GERD include being overweight or obese, pregnancy, use of certain medicines, tobacco use or regular exposure to second-hand smoke. It results from […] More »
EndoGastric Solutions Secures $30.5 Million In New Financing »
July 10, 2018
Existing and New Investors Participated in Support of Rapid Commercialization Redmond, Washington. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that it has secured $30.5 million in new financing led by existing EGS investors Advanced Technology Ventures (ATV), Canaan Partners, Canepa Healthcare, Chicago Growth Partners, CRG, Radius […] More »
EndoGastric Solutions Announces New Data Demonstrating the Feasibility, Safety and Efficacy of EsophyX® Z Device in TIF 2.0 Procedure Following Peroral Endoscopic Myotomy »
June 26, 2018
TIF 2.0 Procedure improves symptoms and esophagitis while reducing acid exposure and decreasing risk associated with long-term proton pump inhibitor use for POEM patients REDMOND, Wash – EndoGastric® Solutions today announced the publication of new clinical data demonstrating the safety and efficacy of the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure in patients with achalasia who have […] More »
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 16
- Next Page »